India-based Alembic Pharmaceuticals has announced the incorporation of a wholly-owned subsidiary in Thailand, named Alembic Pharmaceuticals (Thailand).
The primary objective of this new entity is to explore and establish new business opportunities for the promotion, sale, and distribution of the company’s pharmaceutical products within the Southeast Asian geography.
The subsidiary has commenced with a share capital of 3,000,000 Thai Baht, though it is yet to commence business operations.
This move falls directly within the main line of business for the listed entity. Alembic Pharmaceuticals holds a substantial controlling stake, securing 99.99% of the shareholding in the new foreign subsidiary.
Alembic Pharmaceuticals is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients with vertical integration capabilities.
